scholarly article | Q13442814 |
P356 | DOI | 10.1507/ENDOCRJ.K08E-016 |
P698 | PubMed publication ID | 19088401 |
P2093 | author name string | Keisuke Hirai | |
Yasushi Noguchi | |||
Hiroto Yamashita | |||
Hitoshi Noguchi | |||
Shiro Noguchi | |||
Tsukasa Murakami | |||
Junko Maruta | |||
Tadao Yokoi | |||
P433 | issue | 2 | |
P921 | main subject | thyroid carcinoma | Q18556131 |
anaplastic thyroid carcinoma | Q19000862 | ||
chemotherapy | Q974135 | ||
P304 | page(s) | 245-249 | |
P577 | publication date | 2008-12-17 | |
P1433 | published in | Endocrine Journal | Q5376304 |
P1476 | title | Successful treatment of anaplastic thyroid carcinoma with a combination of oral valproic acid, chemotherapy, radiation and surgery | |
P478 | volume | 56 |
Q41972847 | Activating Transcription Factor 3 regulates in part the enhanced tumour cell cytotoxicity of the histone deacetylase inhibitor M344 and cisplatin in combination |
Q36692105 | Aggressive multimodal approach for anaplastic thyroid cancer and long-term survival |
Q33704599 | Alternative medical treatment for radioiodine-refractory thyroid cancers. |
Q35000792 | Anaplastic thyroid carcinoma: A comprehensive review of current and future therapeutic options |
Q37526750 | Anaplastic thyroid carcinoma: pathogenesis and emerging therapies |
Q33907067 | Chromatin-regulating proteins as targets for cancer therapy |
Q52590685 | Combination Therapy With Histone Deacetylase Inhibitors (HDACi) for the Treatment of Cancer: Achieving the Full Therapeutic Potential of HDACi. |
Q35971504 | Epigenetics modifications and therapeutic prospects in human thyroid cancer. |
Q38128097 | Genetics and epigenetics of sporadic thyroid cancer |
Q26863429 | Histone deacetylase inhibitors as radiosensitisers: effects on DNA damage signalling and repair |
Q92003943 | Key actors in cancer therapy: epigenetic modifiers |
Q38539957 | Opportunities and challenges of radiotherapy for treating cancer |
Q35079955 | Rational therapeutic combinations with histone deacetylase inhibitors for the treatment of cancer |
Q36027160 | RhoB upregulation leads to either apoptosis or cytostasis through differential target selection. |
Q38798863 | Spanish consensus for the management of patients with anaplastic cell thyroid carcinoma. |
Q35194528 | The Beneficial Effects of Valproic Acid in Thyroid Cancer Are Mediated through Promoting Redifferentiation and Reducing Stemness Level: An In Vitro Study |
Q38879058 | The Histone Deacetylase Inhibitor Valproic Acid Sensitizes Gemcitabine-Induced Cytotoxicity in Gemcitabine-Resistant Pancreatic Cancer Cells Possibly Through Inhibition of the DNA Repair Protein Gamma-H2AX. |
Q93090190 | Treatment Outcomes in Anaplastic Thyroid Cancer |
Search more.